Legend Biotech Corporation Q1 Loss Decreases, Beats Estimates

(RTTNews) - Legend Biotech Corporation (LEGN) revealed Loss for first quarter that decreased from the same period last year and beat the Street estimates.

The company's earnings came in at -$59.793 million, or -$0.16 per share. This compares with -$112.101 million, or -$0.34 per share, in last year's first quarter.

Analysts on average had expected the company to earn -$0.34 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 158.7% to $93.991 million from $36.336 million last year.

Legend Biotech Corporation earnings at a glance (GAAP) :

-Earnings (Q1): -$59.793 Mln. vs. -$112.101 Mln. last year. -EPS (Q1): -$0.16 vs. -$0.34 last year. -Revenue (Q1): $93.991 Mln vs. $36.336 Mln last year.